Healthtech Startups
17,197 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
0 investors
CQens designs devices and methods that heat plant-based and medicant-infused formulations to produce aerosols for inhalation, with a focus on harm reduction. The company operates in Nevada and California, holding a portfolio of 111 US and international patents.
0 investors
0 investors
Creative Medical Technology Holdings (CELZ) is a biotechnology company developing regenerative medicine and immunotherapy platforms for conditions in immunology, endocrinology, urogynecology, and orthopedics. Its technologies include autologous immunotherapy (ImmCelz), an allogenic cell platform (AlloStem), a cellular reprogramming platform (iPSCELZ), and rapid autologous therapy programs (StemSpine, OvaStem, CaverStem).
0 investors
Credence MedSystems develops drug delivery and medical device technologies for pharmaceutical manufacturers and healthcare providers. The company is led by executives with extensive backgrounds in medical technology commercialization and surgical device innovation.
0 investors
CredibleMind provides a digital behavioral health platform aimed at improving mental health access, navigation, and early intervention for individuals, organizations, and communities. It works with health systems and healthcare organizations to address behavioral health cost and quality.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Crossover is a stealth-mode medical device company developing two Class II (510(k) pathway) implant systems for ankle fracture fixation, specifically fibular nailing and syndesmosis repair. It targets the US lower-extremity trauma fixation market and is building the devices with an acquisition-oriented strategy for strategic orthopedic partners and surgeon advisors.
0 investors
0 investors
0 investors
0 investors
Croton Healthcare is a healthcare company. The page identifies its board of managers but does not describe the company's specific products or services.
0 investors
0 investors
CryoLife develops technologies for aortic treatment, positioning itself in the cardiovascular medical device field.
0 investors
CryptoMedix Inc. is a pre-clinical biotech developing first-in-class therapeutic antibodies (CMX-101 and CMX-102) targeting the tumor microenvironment for immuno-oncology, promoting cytotoxic T-cell activity and interacting with immune checkpoints such as PD(L)1 and LAG-3. Its CMX-102 antibody is also positioned for use as antibody-drug conjugates and radionuclide conjugates targeting tumor cells.
0 investors
